Cuprina Holdings (Cayman) LTD
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in CUPR.
▼ -95.2% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CNSPCNS Pharmaceuticals, Inc. | $5.52 | — | 0.4x | — | -106.62% | $8.07M |
| ALZNAlzamend Neuro, Inc. | $1.66 | — | 9.7x | — | -373.18% | $8.01M |
| AIDX20/20 Biolabs, Inc. | $0.62 | — | 4.7x | — | -331.22% | $7.97M |
| LUCYInnovative Eyewear Inc | $0.95 |
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Company description provided by Yahoo Finance.
| — |
| 0.9x |
| — |
| -84.58% |
| $8.18M |
| SNGXSoligenix Inc | $0.38 | — | 1.2x | — | -241.65% | $8.2M |
| BMGLBasel Medical Group Ltd | $5.24 | — | 1.7x | — | -147.37% | $8.2M |